Skip to main content
Press release August 7, 2024

Regina Graul, Ph.D., Promoted to Chief Executive Officer

Cyclerion Therapeutics, Inc. (CYCN)

CAMBRIDGE, Mass. , Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced that Regina Graul , Ph.D., has been promoted to Chief Executive Officer, President, and member of the Board of Directors. Since Dr. Graul joined Cyclerion as President in early December
View original release